The Economics of HIV/AIDS in Low-Income Countries: The Case for Prevention
David Canning ()
Additional contact information
David Canning: Harvard School of Public Health
PGDA Working Papers from Program on the Global Demography of Aging
There are two approaches to reducing the burden of sickness and death associated with HIV/AIDS: treatment and prevention. With limited resources, should the focus be on prevention or treatment? I discuss the range of prevention and treatment alternatives, examine their cost effectiveness, and consider various arguments that have been raised against the use of cost-effectiveness analysis in setting priorities for health. I conclude that promoting AIDS treatment using antiretrovirals in resource-constrained countries comes at a huge cost in terms of avoidable deaths that could be prevented through interventions that would substantially lower the scale of the epidemic.
Keywords: HIV; AIDS; low income countries; treatment; prevention (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-afr and nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations View citations in EconPapers (23) Track citations by RSS feed
Downloads: (external link)
Our link check indicates that this URL is bad, the error code is: 404 Not Found (http://www.hsph.harvard.edu/pgda/WorkingPapers/2006/PGDA_WP_18.pdf [301 Moved Permanently]--> https://www.hsph.harvard.edu/pgda/WorkingPapers/2006/PGDA_WP_18.pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: http://EconPapers.repec.org/RePEc:gdm:wpaper:1806
Access Statistics for this paper
More papers in PGDA Working Papers from Program on the Global Demography of Aging
Series data maintained by Cinzia Smothers (). This e-mail address is bad, please contact .